{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T08:18:11Z","timestamp":1777969091877,"version":"3.51.4"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1097\/inf.0000000000001163","type":"journal-article","created":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T17:20:47Z","timestamp":1461086447000},"page":"e229-e238","source":"Crossref","is-referenced-by-count":38,"title":["Respiratory Syncytial Virus Hospitalizations in Healthy Preterm Infants"],"prefix":"10.1097","volume":"35","author":[{"given":"Josephine","family":"Mauskopf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea V.","family":"Margulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miny","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen N.","family":"Lohr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-24-20210202","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis.","volume":"375","author":"Nair","year":"2010","journal-title":"Lancet"},{"key":"R2-24-20210202","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1001\/jamapediatrics.2013.2636","article-title":"Appropriateness of age thresholds for respiratory syncytial virus immunoprophylaxis in moderate-preterm infants: a cohort study.","volume":"167","author":"Winterstein","year":"2013","journal-title":"JAMA Pediatr"},{"key":"R3-24-20210202","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1542\/peds.2014-1665","article-title":"Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection.","volume":"134","year":"2014","journal-title":"Pediatrics"},{"key":"R4-24-20210202","doi-asserted-by":"crossref","first-page":"e620","DOI":"10.1542\/peds.2014-1666","article-title":"Technical report: updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection.","volume":"134","year":"2014","journal-title":"Pediatrics"},{"key":"R6-24-20210202","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/INF.0b013e3182184ae7","article-title":"Epidemiology and prevention of respiratory syncytial virus infections among infants and young children.","volume":"30","author":"Langley","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R7-24-20210202","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/1874285801105010135","article-title":"Epidemiology of respiratory syncytial virus infection in preterm infants.","volume":"5","author":"Resch","year":"2011","journal-title":"Open Microbiol J"},{"key":"R8-24-20210202","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"R10-24-20210202","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jclinepi.2013.06.002","article-title":"Interrater reliability of grading strength of evidence varies with the complexity of the evidence in systematic reviews.","volume":"66","author":"Berkman","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"R11-24-20210202","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/01.inf.0000136869.21397.6b","article-title":"Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain.","volume":"23","author":"Figueras-Aloy","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R12-24-20210202","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/01.inf.0000137568.71589.bd","article-title":"The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation.","volume":"23","author":"Law","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R13-24-20210202","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.anpedi.2009.04.010","article-title":"[Usefulness of different risk factor associations in predicting admissions due to respiratory syncytial virus in premature newborns of 32 to 35 weeks gestation in Spain].","volume":"71","author":"Figueras-Aloy","year":"2009","journal-title":"An Pediatr (Barc"},{"key":"R14-24-20210202","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1515\/jpm-2011-0248","article-title":"The evolution of risk factors for respiratory syncytial virus-related hospitalisation in infants born at 32-35 weeks\u2019 gestational age: time-based analysis using data from the FLIP-2 study.","volume":"40","author":"Carbonell","year":"2012","journal-title":"J Perinat Med"},{"key":"R15-24-20210202","doi-asserted-by":"crossref","first-page":"e59161","DOI":"10.1371\/journal.pone.0059161","article-title":"Prospective validation of a prognostic model for respiratory syncytial virus bronchiolitis in late preterm infants: a multicenter birth cohort study.","volume":"8","author":"Blanken","year":"2013","journal-title":"PLoS One"},{"key":"R16-24-20210202","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/INF.0000000000000219","article-title":"Respiratory syncytial virus disease in preterm infants in the U.S. born at 32-35 weeks gestation not receiving immunoprophylaxis.","volume":"33","author":"Ambrose","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R17-24-20210202","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants.","volume":"102","year":"1998","journal-title":"Pediatrics"},{"key":"R18-24-20210202","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1542\/peds.104.4.894","article-title":"Rehospitalization for respiratory syncytial virus among premature infants.","volume":"104","author":"Joffe","year":"1999","journal-title":"Pediatrics"},{"key":"R19-24-20210202","first-page":"55","article-title":"Respiratory syncytial virus and premature infants born at 32 weeks\u2019 gestation or earlier: hospitalization and economic implications of prophylaxis.","volume":"154","author":"Stevens","year":"2000","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R20-24-20210202","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1542\/peds.2004-0959","article-title":"Direct cost analyses of palivizumab treatment in a cohort of at-risk children: evidence from the North Carolina Medicaid Program.","volume":"114","author":"Wegner","year":"2004","journal-title":"Pediatrics"},{"key":"R21-24-20210202","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/archpediatrics.2010.298","article-title":"Cost-effectiveness of respiratory syncytial virus prophylaxis in various indications.","volume":"165","author":"Hampp","year":"2011","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R22-24-20210202","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1056\/NEJMc1307429","article-title":"Respiratory syncytial virus and recurrent wheeze.","volume":"369","author":"Blanken","year":"2013","journal-title":"N Engl J Med"},{"key":"R23-24-20210202","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1017\/S0950268812001069","article-title":"Hospitalizations for respiratory syncytial virus bronchiolitis in preterm infants at <33 weeks gestation without bronchopulmonary dysplasia: the CASTOR study.","volume":"141","author":"Gouyon","year":"2013","journal-title":"Epidemiol Infect"},{"key":"R24-24-20210202","doi-asserted-by":"crossref","first-page":"e110166","DOI":"10.1371\/journal.pone.0110166","article-title":"Prolonged seasonality of respiratory syncytial virus infection among preterm infants in a subtropical climate.","volume":"9","author":"Hsu","year":"2014","journal-title":"PLoS One"},{"key":"R25-24-20210202","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ppul.1950070309","article-title":"Clinical characteristics of respiratory syncytial virus infections in healthy versus previously compromised host.","volume":"7","author":"Meert","year":"1989","journal-title":"Pediatr Pulmonol"},{"key":"R26-24-20210202","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/00003246-199012000-00009","article-title":"Does prematurity alter the course of respiratory syncytial virus infection?","volume":"18","author":"Meert","year":"1990","journal-title":"Crit Care Med"},{"key":"R27-24-20210202","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0022-3476(05)90000-0","article-title":"Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada.","volume":"121","author":"Navas","year":"1992","journal-title":"J Pediatr"},{"key":"R28-24-20210202","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0022-3476(96)70294-9","article-title":"Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. Pediatric Critical Study Group.","volume":"128","author":"Moler","year":"1996","journal-title":"J Pediatr"},{"key":"R29-24-20210202","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1542\/peds.99.3.e7","article-title":"Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database.","volume":"99","author":"Law","year":"1997","journal-title":"Pediatrics"},{"key":"R30-24-20210202","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2165\/00128072-200002020-00005","article-title":"Respiratory syncytial virus immunoprophylaxis: impact on epidemiology.","volume":"2","author":"Dougherty","year":"2000","journal-title":"Paediatr Drugs"},{"key":"R31-24-20210202","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1542\/peds.112.3.548","article-title":"Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use.","volume":"112","author":"Prais","year":"2003","journal-title":"Pediatrics"},{"key":"R32-24-20210202","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1002\/jmv.21026","article-title":"Respiratory syncytial virus infections in hospitalized infants: association between viral load, virus subgroup, and disease severity.","volume":"79","author":"Fodha","year":"2007","journal-title":"J Med Virol"},{"key":"R33-24-20210202","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1067\/S0022-3476(03)00513-4","article-title":"Morbidity and mortality after RSV-associated hospitalizations among premature Canadian infants.","volume":"143","author":"Sampalis","year":"2003","journal-title":"J Pediatr"},{"key":"R34-24-20210202","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jpeds.2007.02.032","article-title":"Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing.","volume":"151","author":"Simoes","year":"2007","journal-title":"J Pediatr"},{"key":"R35-24-20210202","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ppul.21244","article-title":"Healthcare costs within a year of respiratory syncytial virus among Medicaid infants.","volume":"45","author":"Palmer","year":"2010","journal-title":"Pediatr Pulmonol"},{"key":"R36-24-20210202","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1185\/03007995.2010.542744","article-title":"Respiratory outcomes, utilization and costs 12 months following a respiratory syncytial virus diagnosis among commercially insured late-preterm infants.","volume":"27","author":"Palmer","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"R37-24-20210202","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1017\/S0950268813001738","article-title":"Respiratory morbidity of preterm infants of less than 33 weeks gestation without bronchopulmonary dysplasia: a 12-month follow-up of the CASTOR study cohort.","volume":"142","author":"Fauroux","year":"2014","journal-title":"Epidemiol Infect"},{"key":"R38-24-20210202","doi-asserted-by":"crossref","first-page":"e1474","DOI":"10.1542\/peds.2014-2742","article-title":"Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis.","volume":"134","author":"Ralston","year":"2014","journal-title":"Pediatrics"},{"key":"R39-24-20210202","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1164\/rccm.200809-1471OC","article-title":"Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study.","volume":"179","author":"Thomsen","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"R40-24-20210202","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1183\/09031936.00009314","article-title":"Decreased lung function precedes severe respiratory syncytial virus infection and post-respiratory syncytial virus wheeze in term infants.","volume":"44","author":"Zomer-Kooijker","year":"2014","journal-title":"Eur Respir J"},{"key":"R41-24-20210202","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1067\/mpd.2000.110531","article-title":"Rates of hospitalization for respiratory syncytial virus infection among children in medicaid.","volume":"137","author":"Boyce","year":"2000","journal-title":"J Pediatr"},{"key":"R42-24-20210202","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00431-002-1105-7","article-title":"Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany.","volume":"162","author":"Liese","year":"2003","journal-title":"Eur J Pediatr"},{"key":"R43-24-20210202","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1542\/peds.100.6.e8","article-title":"Rehospitalization with respiratory syncytial virus after neonatal intensive care unit discharge: A 3-year follow-up.","volume":"100","author":"Nachman","year":"1997","journal-title":"Pediatrics"},{"key":"R44-24-20210202","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1097\/01.inf.0000246978.58565.b5","article-title":"The risk of respiratory syncytial virus-related hospitalizations in preterm infants of 29 to 35 weeks\u2019 gestational age.","volume":"25","author":"Doering","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R45-24-20210202","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/adc.83.4.313","article-title":"Respiratory syncytial virus infection in high risk infants and the potential impact of prophylaxis in a United Kingdom cohort.","volume":"83","author":"Clark","year":"2000","journal-title":"Arch Dis Child"},{"key":"R46-24-20210202","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/adc.88.12.1065","article-title":"The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area.","volume":"88","author":"Deshpande","year":"2003","journal-title":"Arch Dis Child"},{"key":"R47-24-20210202","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/00006454-200007000-00002","article-title":"Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: a prospective study. IRIS Study Group.","volume":"19","author":"Carbonell-Estrany","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R48-24-20210202","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/00006454-200109000-00010","article-title":"Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons.","volume":"20","author":"Carbonell-Estrany","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"R49-24-20210202","doi-asserted-by":"crossref","first-page":"F64","DOI":"10.1136\/adc.2003.029710","article-title":"Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis.","volume":"90(1)","author":"Heikkinen","year":"2005","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"R50-24-20210202","first-page":"93","article-title":"The PREVENT Study Group.","volume":"99","year":"1997","journal-title":"Pediatrics"},{"key":"R51-24-20210202","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/01.inf.0000086403.50417.7c","article-title":"Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants.","volume":"22","author":"Pedraz","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R52-24-20210202","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ppul.10169","article-title":"Readmission with respiratory syncytial virus (RSV) infection among graduates from a neonatal intensive care unit.","volume":"34","author":"McCormick","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"R53-24-20210202","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/01.inf.0000069768.34383.18","article-title":"Impact of palivizumab prophylaxis on respiratory syncytial virus hospitalizations in high risk Alaska Native infants.","volume":"22","author":"Singleton","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R54-24-20210202","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jinf.2004.06.015","article-title":"Rehospitalisations for respiratory disease and respiratory syncytial virus infection in preterm infants of 29-36 weeks gestational age.","volume":"50","author":"Resch","year":"2005","journal-title":"J Infect"},{"key":"R55-24-20210202","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s10096-005-0082-y","article-title":"Observational study of respiratory syncytial virus-associated hospitalizations and use of palivizumab in premature infants aged 29-32 weeks.","volume":"25","author":"Resch","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R56-24-20210202","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/INF.0b013e3181710990","article-title":"FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks.","volume":"27","author":"Figueras-Aloy","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R57-24-20210202","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1542\/peds.2013-0303","article-title":"Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age.","volume":"132","author":"Hall","year":"2013","journal-title":"Pediatrics"},{"key":"R58-24-20210202","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.earlhumdev.2015.06.009","article-title":"Healthy Late-preterm infants born 33-36+6 weeks gestational age have higher risk for respiratory syncytial virus hospitalization.","volume":"91","author":"Helfrich","year":"2015","journal-title":"Early Hum Dev"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000001163","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:10:53Z","timestamp":1620954653000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201607000-00024"}},"subtitle":["Systematic Review"],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001163","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}